We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$338B
AUM Growth
+$13.2B
Cap. Flow
-$8.05B
Cap. Flow %
-2.38%
Top 10 Hldgs %
23.21%
Holding
3,478
New
75
Increased
881
Reduced
2,243
Closed
162

Sector Composition

Rank Sector Weight
1 Technology 26.36%
2 Consumer Discretionary 12.42%
3 Healthcare 12.26%
4 Financials 12.2%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYD icon
3176
China Yuchai International
CYD
$1.78B
$284K ﹤0.01%
19,037
-43,062
-69% -$542K
PBYI icon
3177
Puma Biotechnology
PBYI
$454M
$283K ﹤0.01%
99,561
-9,708
-9% -$42.1K
AMPE
3178
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$280K ﹤0.01%
1,606
-219
-12% -$81.7K
FWRG icon
3179
First Watch Restaurant Group
FWRG
$766M
$279K ﹤0.01%
+16,618
New +$331K
SBDS
3180
DELISTED
Solo Brands Inc
SBDS
$278K ﹤0.01%
+444
New +$305K
DH icon
3181
Definitive Healthcare
DH
$75.3M
$277K ﹤0.01%
+10,139
New +$355K
FXLV
3182
DELISTED
F45 Training Holdings Inc.
FXLV
$276K ﹤0.01%
26,460
-13,107
-33% -$164K
VV icon
3183
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$275K ﹤0.01%
1,246
PRCT icon
3184
Procept Biorobotics
PRCT
$1.17B
$274K ﹤0.01%
+10,972
New +$406K
SGHT icon
3185
Sight Sciences
SGHT
$412M
$272K ﹤0.01%
14,316
FTH
3186
Faeth Therapeutics
FTH
$629M
$271K ﹤0.01%
2,577
-240
-9% -$35.9K
STON
3187
DELISTED
StoneMor Inc.
STON
$271K ﹤0.01%
124,591
-17,224
-12% -$43.2K
SWT
3188
DELISTED
Stanley Black & Decker, Inc.
SWT
0
GLSI icon
3189
Greenwich LifeSciences
GLSI
$211M
$264K ﹤0.01%
9,575
DAWN
3190
DELISTED
Day One Biopharmaceuticals
DAWN
$260K ﹤0.01%
14,961
PAA icon
3191
Plains All American Pipeline
PAA
$16.1B
$259K ﹤0.01%
27,685
-2,724
-9% -$27.4K
TYRA icon
3192
Tyra Biosciences
TYRA
$1.58B
$259K ﹤0.01%
+18,400
New +$366K
GBL
3193
DELISTED
GAMCO Investors, Inc.
GBL
$254K ﹤0.01%
10,736
RVP icon
3194
Retractable Technologies
RVP
$20.1M
$252K ﹤0.01%
37,822
INZY
3195
DELISTED
Inozyme Pharma
INZY
$251K ﹤0.01%
42,261
-5,401
-11% -$46.6K
XOMA
3196
DELISTED
Xoma
XOMA
$251K ﹤0.01%
12,486
-12,477
-50% -$292K
SLAI
3197
DELISTED
SOLAI Ltd ADS
SLAI
$247K ﹤0.01%
574
-23
-4% -$12.6K
IMRX icon
3198
Immuneering
IMRX
$292M
$247K ﹤0.01%
11,760
CDRE icon
3199
Cadre Holdings
CDRE
$1.41B
$246K ﹤0.01%
+9,681
New +$196K
SOL
3200
DELISTED
Emeren Group
SOL
$246K ﹤0.01%
41,200

Similar funds

Nuveen's Q4 2021 Portfolio in Review

As of Q4 2021, Nuveen held 3,478 positions worth $338B, up 4.1% from $325B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q4 2021 filing shows 75 new, 881 increased, 2,243 reduced and 162 closed positions. Its largest new stake was Roblox: 1,368,944 shares worth $141M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $1.18B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Nuveen's largest Q4 2021 buy was Roblox: 1,368,944 shares worth $141M.
  • Nuveen added most to Nuveen Growth Opportunities ETF in Q4 2021, an estimated $3.24B increase.
  • Nuveen's biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.18B.
  • Nuveen fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $102M.
  • Nuveen's ten largest holdings make up 23% of its $338B portfolio in Q4 2021.
  • Nuveen opened 75 new positions and closed 162 in Q4 2021.
  • Nuveen's portfolio value rose 4.1% quarter-over-quarter to $338B.

Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.